Venture capital Archives

News and Trends 23 Feb 2023

Italian life sciences fund hits €175M

Panakès Partners, an Italian venture capital firm in the life sciences sector, has closed its Purple Fund with a total of €175 million ($185.4 million). Panakès Purple Fund is currently the largest Italian Venture Capital Fund, in the investment phase, dedicated to life sciences, with an investment focus in Italy and Europe, as well as […]

February 23, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 11 Jan 2023

Five key trends shaping life sciences in 2023

By Kevin Wayer, president – government, education, infrastructure and life sciences industries, JLL, and Travis McCready, head of life sciences, industries Americas, JLL After an unprecedented period of growth during the pandemic, life sciences activity normalized in 2022. The life sciences industry has not been immune to the macroeconomic challenges plaguing the global economy, but […]

January 11, 2023 - 5 minutesmins - By External Contributor

In Depth 9 Jan 2023

The biggest private biotech investments in December 2022

The companies Apogee Therapeutics, Pulmocide and Qitan Technology bagged the biggest biotech investments in December 2022. Around the world, immunology and manufacturing players attracted the biggest funding rounds. We’ve hit 2023 and a lot of biotech fundraising took place in the final month of 2022. We’ve gathered the biggest biotech investments that went to private […]

January 9, 2023 - 3 minutesmins - By Jonathan Smith

News and Trends 6 Dec 2022

Avalon BioVentures to invest in early-stage biotech

L.P., a venture capital firm dedicated to early-stage biomedical innovation, has closed its first venture fund, ABV1, with $135 million in funding from new and existing institutional investors. Avalon BioVentures emerged from Avalon Ventures’ shared life-science/high-tech investing funds as a life-science only fund and will continue to leverage Avalon’s team and company accelerator to create, […]

December 6, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 6 Dec 2022

Startup Graegis developing therapies for radiation side-effects

Graegis Pharmaceuticals, a startup developing new therapies aimed at preventing the side effects of radiotherapies, is set to complete the regulatory nonclinical package allowing entry in clinical trials. The company, founded in the last quarter of 2021, spent the first year of operations running critical experiments on the new therapies, which will target radiation side […]

December 6, 2022 - 2 minutesmins - By Liza Laws

In Depth 5 Dec 2022

The biggest private biotech investments in November 2022

The companies Emalex Biosciences, Osler Diagnostics and TauRx Pharmaceuticals bagged the biggest biotech investments in November 2022. Around the world, oncology and cell therapy players attracted the biggest funding rounds. We’re approaching the December holidays and, while lower than in 2021, biotech stocks overall have stayed relatively flat in the last few months. In the […]

December 5, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 1 Nov 2022

J.P. Morgan launches life sciences private capital team

J.P. Morgan Asset Management has announced the launch of a new life sciences private equity team, Life Sciences Private Capital. The new team will invest in early and growth stage healthcare companies across multiple strategies aligned to specific market opportunities, with a focus on novel therapeutics and technologies in several target areas. These include genetic […]

November 1, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 20 Sep 2022

Dyania Health raises $5.3M to help speed up clinical trials

Dyania Health was founded in 2019 to address a significant and unsolved problem for clinical trials. That is, the process of manual chart review to pre-screening patients for clinical research is cumbersome and time-consuming. The process to match patients on very specific and time-sensitive clinical trial criteria typically takes 18 to 24 months for most […]

September 20, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 13 Sep 2022

WhiteLab Genomics raises $10M for AI-powered genomic therapies platform

WhiteLab Genomics has announced the completion of a $10 million funding round. The round was led by French venture capital firm Omnes Capital, and Debiopharm, a Switzerland based biopharmaceutical company with a venture arm focused on digital health. WhiteLab Genomics said it aims to “revolutionize genomic therapy development” using public and private data and in-house […]

September 13, 2022 - 3 minutesmins - By Jim Cornall

cancer shutterstock immunotherapy deep science ventures

News and Trends 26 Jul 2022

Deep Science Ventures deepens CRUK pact to co-found oncology startups

The venture builder Deep Science Ventures (DSV) has expanded an existing alliance with Cancer Research UK’s innovation-focused arm Cancer Research Horizons, with the mission to establish new oncology startups in the U.K. Just months after Cancer Research UK (CRUK) established its industry-orientated division Cancer Research Horizons, the research charity has doubled down on a collaboration […]

July 26, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 22 Jul 2022

Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma

On this week’s podcast, our guests are Jeremy Skillington, CEO of Poolbeg Pharma; Dani Bach, and Eric Moessinger, both partners at +ND Capital; and Louise Modis, chief scientific officer at Mogrify. Poolbeg Pharma gets approval for severe influenza drug trial Poolbeg Pharma, a clinical stage infectious disease pharmaceutical company, has received ethics and competent authority […]

July 22, 2022

Optics11 Life receives €5 million in funding for drug development

News and Trends 18 Jul 2022

FORTY51 Ventures closes $43M biotech fund and announces first investment

FORTY51 Ventures has announced the closing of FORTY51 Ventures I, raising $43 million in its first close. FORTY51’s core strategy focuses on company formation and early-stage investments in biotech with geographic emphasis on Switzerland, France and Germany. FORTY51 Ventures will lead or co-lead early rounds (seed and series A) of its growing portfolio, which will […]

July 18, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Venture capital

Italian life sciences fund hits €175M

Five key trends shaping life sciences in 2023

The biggest private biotech investments in December 2022

Avalon BioVentures to invest in early-stage biotech

Startup Graegis developing therapies for radiation side-effects

The biggest private biotech investments in November 2022

J.P. Morgan launches life sciences private capital team

Dyania Health raises $5.3M to help speed up clinical trials

WhiteLab Genomics raises $10M for AI-powered genomic therapies platform

Deep Science Ventures deepens CRUK pact to co-found oncology startups

Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma

FORTY51 Ventures closes $43M biotech fund and announces first investment

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!